BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8854075)

  • 1. Human papillomavirus in tissue of bladder and bladder carcinoma specimens. A preliminary study.
    Ludwig M; Köchel HG; Fischer C; Ringert RH; Weidner W
    Eur Urol; 1996; 30(1):96-102. PubMed ID: 8854075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus associated with bladder carcinoma? Analysis by polymerase chain reaction.
    Tekin MI; Tuncer S; Aki FT; Bilen CY; Aygün C; Ozen H
    Int J Urol; 1999 Apr; 6(4):184-6. PubMed ID: 10226835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients.
    Ben Selma W; Ziadi S; Ben Gacem R; Amara K; Ksiaa F; Hachana M; Trimeche M
    Pathol Res Pract; 2010 Nov; 206(11):740-3. PubMed ID: 20674191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomas.
    Lu QL; Lalani el-N ; Abel P
    Eur Urol; 1997; 31(4):428-32. PubMed ID: 9187902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses.
    Noel JC; Thiry L; Verhest A; Deschepper N; Peny MO; Sattar AA; Schulman CC; Haot J
    Urology; 1994 Nov; 44(5):671-5. PubMed ID: 7974942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa.
    Sur M; Cooper K; Allard U
    Pathology; 2001 Feb; 33(1):17-20. PubMed ID: 11280602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder.
    Aynaud O; Tranbaloc P; Orth G
    J Urol; 1998 Jan; 159(1):86-9; discussion 90. PubMed ID: 9400443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human papillomavirus DNA sequences in cancer of the urinary bladder by in situ hybridisation and polymerase chain reaction.
    Gopalkrishna V; Srivastava AN; Hedau S; Sharma JK; Das BC
    Genitourin Med; 1995 Aug; 71(4):231-3. PubMed ID: 7590714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation.
    De Gaetani C; Ferrari G; Righi E; Bettelli S; Migaldi M; Ferrari P; Trentini GP
    J Clin Pathol; 1999 Feb; 52(2):103-6. PubMed ID: 10396236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type 16 associated with multifocal transitional cell carcinomas of the bladder in two transplanted patients.
    Noel JC; Peny MO; Mat O; Antoine M; Firket C; Detremmerie O; Thiry L; Verhest A; Vereerstraeten P
    Transpl Int; 1994 Aug; 7(5):340-3. PubMed ID: 7993570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus DNA as a factor determining the survival of bladder cancer patients.
    Lopez-Beltran A; Escudero AL; Vicioso L; Muñoz E; Carrasco JC
    Br J Cancer; 1996 Jan; 73(1):124-7. PubMed ID: 8554974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aetiological significance of human papillomavirus in bladder cancer.
    Boucher NR; Scholefield JH; Anderson JB
    Br J Urol; 1996 Dec; 78(6):866-9. PubMed ID: 9014710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization.
    Lopez-Beltran A; Muñoz E
    Histopathology; 1995 Jun; 26(6):565-9. PubMed ID: 7665148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urethral condylomata, due to human papilloma virus (HPV) type 6/11., associated with transitional cell tumors in the bladder and ureter. A case report.
    Olsen S; Marcussen N; Jensen KM; Lindeberg H
    Scand J Urol Nephrol Suppl; 1995; 172():51-5. PubMed ID: 8578257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer.
    Gazzaniga P; Vercillo R; Gradilone A; Silvestri I; Gandini O; Napolitano M; Giuliani L; Fioravanti A; Gallucci M; Aglianò AM
    J Med Virol; 1998 Aug; 55(4):262-7. PubMed ID: 9661833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction.
    Chan KW; Wong KY; Srivastava G
    J Clin Pathol; 1997 Dec; 50(12):1018-21. PubMed ID: 9516885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
    Carter JJ; Madeleine MM; Shera K; Schwartz SM; Cushing-Haugen KL; Wipf GC; Porter P; Daling JR; McDougall JK; Galloway DA
    Cancer Res; 2001 Mar; 61(5):1934-40. PubMed ID: 11280749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis.
    Youshya S; Purdie K; Breuer J; Proby C; Sheaf MT; Oliver RT; Baithun S
    J Clin Pathol; 2005 Feb; 58(2):207-10. PubMed ID: 15677544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of human papillomavirus via chemiluminescence technic and polymerase chain reaction in transitional cell carcinoma of the bladder].
    Giudici C; Ferrario D; Forlani N; Piatti B; Paulesu A
    Pathologica; 1998 Dec; 90(6):776-82. PubMed ID: 10220998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Cell Differentiation in HPV-Associated Bladder Cancer.
    Golovina DA; Ermilova VD; Zavalishina LE; Andreeva YY; Matveev VB; Frank GA; Volgareva GM
    Bull Exp Biol Med; 2016 May; 161(1):96-8. PubMed ID: 27265130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.